FDA Panel Approves Single-Shot J&J COVID Vaccine

NBC News reports:

An independent advisory panel to the Food and Drug Administration voted Friday to recommend that the agency authorize Johnson & Johnson’s Covid-19 vaccine. Members of the Vaccines and Related Biological Products Advisory Committee, or VRBPAC, voted unanimously in favor of recommending authorization.

The FDA is not required to go along with the committee’s recommendation, but is widely expected to, and could possibly issue an emergency use authorization as soon as Friday evening or Saturday. It would be the third Covid-19 vaccine authorized in the U.S., in addition to vaccines from drugmakers Moderna and Pfizer.

Read the full article.